Geriatric Thoracic Surgery Ambulation Challenge

Description

This study is examining collecting data on steps walked (ambulation) per day by thoracic surgery patients over the age of 65 years-old before surgery. The name(s) of the study device involved in this study is: * Fitbit inspire

Conditions

Thoracic Diseases, Surgery, Therapy, Exercise

Study Overview

Study Details

Study overview

This study is examining collecting data on steps walked (ambulation) per day by thoracic surgery patients over the age of 65 years-old before surgery. The name(s) of the study device involved in this study is: * Fitbit inspire

Pre-Operative Exercise Challenge In Geriatric Thoracic Patients

Geriatric Thoracic Surgery Ambulation Challenge

Condition
Thoracic Diseases
Intervention / Treatment

-

Contacts and Locations

Boston

Brigham and Women's Hospital, Boston, Massachusetts, United States, 02115

Boston

Dana-Farber Cancer Institute, Boston, Massachusetts, United States, 02215

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients Aged ≥ 65 years
  • * Who are preparing to undergo thoracic surgery at Brigham and Women's Hospital (BWH)
  • * Patients who are completely non-ambulatory (i.e. wheelchair-bound-patients) \*
  • * Those who lack capacity to consent due to cognitive disease.
  • * Patient for which surgery is felt to be more urgent and therefore performed earlier then our required timeframe for intervention.
  • * Patients with cardiac disease or angina for which formal cardiac testing is required for clearance.
  • * Our exclusion criteria do not include patients with gait disturbances or those who require assistance devices for ambulation.

Ages Eligible for Study

65 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Dana-Farber Cancer Institute,

Michael T Jaklitsch, MD, PRINCIPAL_INVESTIGATOR, Brigham and Women's Hospital

Study Record Dates

2024-12-23